• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Adaptive Biotechnologies Corp (NQ: ADPT )

    4.040 -0.190 (-4.49%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 874,537
    Open 4.220
    Bid (Size) 3.900 (1)
    Ask (Size) 4.150 (22)
    Prev. Close 4.230
    Today's Range 4.020 - 4.270
    52wk Range 2.280 - 8.510
    Shares Outstanding 144,311,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    3 Precision Medicine Stocks Tailoring Treatments
    With technological developments pushing the boundaries of healthcare, these are the precision medicine stocks to consider. 
    Via InvestorPlace
    Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024
    From Adaptive Biotechnologies
    Via GlobeNewswire

    Performance

    YTD
    -15.30%
    -15.30%
    1 Month
    +24.69%
    +24.69%
    3 Month
    +60.96%
    +60.96%
    6 Month
    -4.72%
    -4.72%
    1 Year
    -48.21%
    -48.21%

    More News

    Read More
    Cathie Wood-Led Ark Invest Scoops Up $5.16M Worth Of Palantir Shares Amid Raging AI Fervor
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Trading SMID Biotech Stocks In A Volatile Market
    Via Talk Markets
    Adaptive Biotechnologies: Q4 Earnings Insights
    Via Benzinga
    Earnings Scheduled For February 14, 2024
    Via Benzinga
    Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Mighty Mites: 3 Small-Cap Stocks Packing a Powerful Punch
    Via InvestorPlace
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
    Via The Motley Fool
    Why Adaptive Biotechnologies Topped the Market Today
    Via The Motley Fool
    ADPT Stock Earnings: Adaptive Biotechnologies Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Netflix, ON Semiconductor And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga
    Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Adaptive Biotechnologies Names New CFO Preserves Strong Capital Position
    Via Benzinga
    Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    The 7 Best Penny Stocks to Buy in Q2 2024
    Via InvestorPlace
    Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
    From Adaptive Biotechnologies
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
    From Adaptive Biotechnologies
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.